Some research indicates that the HER2 signaling pathway may indirectly regulate PD-L1 expression, possibly through activation of the PI3K/AKT/mTOR pathway or by promoting the secretion of immunosuppressive cytokines in the tumor microenvironment (34). The gene discussed is ERBB2; the disease is neoplasm.